GlaxoSmithKline, Johnson & Johnson, and other pharma companies are actively recruiting technologists from companies like Google and Microsoft’s LinkedIn, to help modernize the processes that big pharma uses to discover and develop new drugs. According to a GSK spokesperson, there are plenty of opportunities for tech workers to build machine learning tools that analyze health information. An ongoing project may use previously-collected clinical trial data as an alternative to a control arm in a study, which could potentially reduce the cost of clinical trials and provide a better patient experience. (CNBC)